DarioHealth Corp. (DRIO)
Company Description
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand.
The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems.
It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching.
The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016.
DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Country | United States |
IPO Date | Mar 14, 2016 |
Industry | Medical - Diagnostics & Research |
Sector | Healthcare |
Employees | 196 |
CEO | Erez Raphael |
Contact Details
Address: 18 West 18th Street New York, New York United States | |
Website | https://www.mydario.com |
Stock Details
Ticker Symbol | DRIO |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001533998 |
CUSIP Number | 23725P209 |
ISIN Number | US23725P2092 |
Employer ID | 45-2973162 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Erez Raphael | Chief Executive Officer & Director |
Limor Drezner | Chief People Officer |
Tomer Ben-Kiki | Chief Technology Officer |
Zvi Ben David CPA | Chief Financial Officer, Treasurer & Secretary |
Claudia Levi | Content & Communications Manager |
Dov Oppenheim | Co-Founder & Production Chief |
Kat Parrella | Investor Relations Manager |
Lara Dodo | Chief Operations Officer |
Mona Dean | Chief Compliance Officer |
Steven C. Nelson | Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 29, 2025 | 8-K | Current Report |
May 28, 2025 | S-3 | Filing |
May 21, 2025 | 8-K | Current Report |
May 20, 2025 | PRE 14A | Filing |
May 15, 2025 | 4 | Filing |
May 15, 2025 | 3 | Filing |
May 14, 2025 | 10-Q | Quarterly Report |
May 13, 2025 | SCHEDULE 13G/A | [Amend] Filing |
May 06, 2025 | 8-K | Current Report |
Apr 28, 2025 | 8-K | Current Report |